[HTML][HTML] Phase II trial of sorafenib in metastatic thyroid cancer

…, J Liang, PE Wakely Jr, VV Vasko, M Saji… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
… Slides were prepared from cell blocks as previously described (Vasko V, Saji M, Hardy E,
et al: J Med Genet 41:161-170, 2004) and incubated overnight at 4C with antibodies against …

[HTML][HTML] Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

…, NC Hall, PE Wakely Jr, VV Vasko, M Saji… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Mutations in the RET proto-oncogene and vascular endothelial growth factor
receptor (VEGFR) activity are critical in the pathogenesis of medullary thyroid cancer (MTC). …

Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

…, GL Francis, A De La Chapelle, M Saji… - Proceedings of the …, 2007 - National Acad Sciences
Papillary thyroid carcinomas (PTCs) that invade into local structures are associated with a
poor prognosis, but the mechanisms for PTC invasion are incompletely defined, limiting the …

Overexpression and overactivation of Akt in thyroid carcinoma

…, H Burch, V Bernet, KD Burman, LD Kohn, M Saji - Cancer research, 2001 - AACR
Enhanced activation of Akt occurs in Cowden’s disease, an inherited syndrome of follicular
thyroid, breast, colon, and skin tumors, via inactivation of its regulatory protein, PTEN. …

[HTML][HTML] Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia

…, MER Butchbach, Z Sahenk, H Wang, M Saji… - Cancer cell, 2005 - cell.com
Cachexia contributes to nearly a third of all cancer deaths, yet the mechanisms underlying
skeletal muscle wasting in this syndrome remain poorly defined. We report that tumor-induced …

[HTML][HTML] Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers

T Bekaii-Saab, MA Phelps, X Li, M Saji… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Biliary cancers (BCs) carry a poor prognosis, but targeting the RAS/RAF/mitogen-activated
protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) pathway is of …

The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors

M Saji, MD Ringel - Molecular and cellular endocrinology, 2010 - Elsevier
The phosphoinositide-3 (OH) kinase (PI3K) signaling cascade is involved in regulating
glucose uptake and metabolism, growth, motility, and other essential functions for cell survival. …

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells

…, F Schuppert, KD Burman, M Saji - The Journal of …, 2002 - academic.oup.com
The development of distant metastasis is the most important predictor of death from thyroid
cancer. KiSS-1 is a recently cloned human metastasis suppressor gene whose product, …

SRGAP1 Is a Candidate Gene for Papillary Thyroid Carcinoma Susceptibility

…, R Nagy, W Li, Y Huang, K Akagi, M Saji… - The Journal of …, 2013 - academic.oup.com
Background: Papillary thyroid carcinoma (PTC) shows high heritability, yet efforts to find
predisposing genes have been largely negative. Objectives: The objective of this study was to …

Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination

…, CD Morrison, A Frilling, M Saji… - The Journal of …, 2005 - academic.oup.com
Thyroid carcinoma is a common endocrine cancer with a favorable prognosis if subjected to
timely treatment. However, the clinical identification of follicular thyroid carcinoma (FTC) …